not told what the ultrasound diagnoses in the other 21 was, presumably dilatation of unknown cause. Cystic renal dysplasia can be accurately diagnosed by ultrasound in most cases if the strict criteria of non-communicating cystic spaces, which vary in size and number, is adhered to. It is well recognised that in a few cases it may be difficult to differentiate from hydronephrosis but this is readily achieved either by cyst puncture or radionuclide scintigraphy. It is, however, good practice in all cases to perform a dimercaptosuccinic acid (DMSA) scintigram to confirm total absence of function.
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The place of postnatal renal tract ultrasound is quite clear. It should act as a guide to the next examination, although in many cases the specific diagnosis will be apparent. Tudor and Whitaker have recently described a protocol for the detection and management of the dilated fetal urinary tract, which is to be commended. The children who participated in the Jamaican cohort study of sickle cell disease were aged between 6 and 14 years at the date of the study. Gall stone prevalence was determined by real time ultrasound in a cross sectional study with informed consent in every case. Details of the number of children with each genotype, the total examined, and the prevalence of gall stones are given in the Clonidine also causes release of luteinising hormone in rats, however, and restoration of suppressed luteinising hormone pulsatility.2 3 This observation could have important implications for the treatment of short children because clonidine might induce puberty. We report the effects of clonidine on serum gonadotrophins in normal subjects.
Clonidine (0-15 mg/m2 orally) was given at 09.00 (time 0) to eight healthy adult men volunteers and placebo to one subject. Twelve blood samples to measure luteinising hormone and follicle stimulating hormone were drawn at 15 minute intervals between -45 and 120 minutes through an indwelling venous cannula. Blood pressure was determined every 15 minutes throughout the test. The blood samples were centrifuged and the serum stored at -20°C until assay. Luteinising hormone and follicle stimulating hormone assays were performed by immunoradiometric assay kits from the North East Thames Regional Immunoassay Scheme in duplicates and the concentrations were measured as IU/I. Alpha, adrenergic blockers reduce the frequency of luteinising hormone pulses and suppress pulsatile release of luteinising hormone in animals, implying that the major effect of the alpha adrenergic system is to stimulate gonadotrophin releasing hormone release.4 When clonidine was administered to rats with abolished luteinising hormone pulsatility, it re-established luteinising hormone pulsatility and increased the secretion of luteinising hormone.2 3 The affinity of clonidine for the alpha, receptor is 70-500 times weaker than its affinity for alpha2 receptor but it shows an effect on alpha, receptors when given in large doses.5
The reason why clonidine affected luteinising hormone pulsatility in the rats was that it was given in large doses. The small doses used in this study were effective on the alpha2 receptors with no apparent effect on luteinising hormone pulsatility.
